Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001171520-21-000078
Filing Date
2021-02-12
Accepted
2021-02-12 17:25:31
Documents
1
Group Members
HABIB KAIROUZJOSHUA RUCHMARK LESCHLYRHO CAPITAL PARTNERS LLCRHO VENTURES V AFFILIATES, L.L.C.RHO VENTURES V, L.P.RMV V, L.L.C.

Document Format Files

Seq Description Document Type Size
1 eps9487.htm SC 13G/A 138795
  Complete submission text file 0001171520-21-000078.txt   140616
Mailing Address C/O RHO CAPITAL PARTNERS, INC. 152 WEST 57TH STREET, 23RD FLOOR NEW YORK NY 10019
Business Address C/O RHO CAPITAL PARTNERS, INC. 152 WEST 57TH STREET, 23RD FLOOR NEW YORK NY 10019 212-751-6677
Rho Ventures V, L.P. (Filed by) CIK: 0001325383 (see all company filings)

EIN.: 201953730 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-243-5555
NGM BIOPHARMACEUTICALS INC (Subject) CIK: 0001426332 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90978 | Film No.: 21629891
SIC: 2834 Pharmaceutical Preparations